Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine for CRP reduction in sepsis
IRCT20230626058586N13Phase 3Recruiting
- Sponsor
- Tehran University of Medical Sciences
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of acetylcysteine in sepsis (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Blood C-reactive protein level. Started Oct 2026; status: recruiting.
02
Drugs
acetylcysteine
03
Conditions
sepsis
Beyond the preview
Go deeper on IRCT20230626058586N13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230626058586N13.